Robert R Ruffolo Sigilon Therapeutics, Inc. (SGTX) insider trading activity

SGTX Quotes by TradingView

Robert R Ruffolo is of Sigilon Therapeutics, Inc.. Currently has a direct ownership of 0 shares of SGTX, which is worth approximately $0. The most recent transaction as insider was on Jul 01, 2021, when has been sold 6,750 shares (Common Stock) at a price of $10.36 per share, resulting in proceeds of $69,930. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

ROBERT R RUFFOLO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2021
SELL
Open market or private sale
$69,930 $10.36 p/Share
6,750 Reduced 100.0%
0 Common Stock
Jul 01 2021
BUY
Exercise of conversion of derivative security
$3,847 $0.57 p/Share
6,750 Added 50.0%
6,750 Common Stock

Also insider at

ARDS
Aridis Pharmaceuticals, Inc. Healthcare
Director
ANGN
Angion Biomedica Corp. Healthcare
Director
RRR

Robert R Ruffolo

Cambridge, MA

Track Institutional and Insider Activities on SGTX

Follow Sigilon Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGTX shares.

Notify only if

Insider Trading

Get notified when an Sigilon Therapeutics, Inc. insider buys or sells SGTX shares.

Notify only if

News

Receive news related to Sigilon Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SGTX